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Abstract
Background. Left ventricular (LV) diastolic dysfunction is
linked to myocardial collagen content in many cardiac dis-
eases. There are no data regarding such relationship in pa-
tients with end-stage renal disease (ESRD) undergoing
haemodialysis.
Methods. Twenty-five patients with ESRD undergoing
haemodialysis were studied by echocardiography. LV dia-
stolic function was investigated by Doppler echocardiogra-
phy, by analysing LV filling velocities at rest and during
loading manoeuvres, which represent an estimate of LV
filling pressure. According to the Doppler pattern, LV fill-
ing pressure in a given patient was judged to be normal or
slightly increased or to be moderately or severely in-
creased. The presence of myocardial fibrosis was estimat-
ed by ultrasound tissue characterization with integrated
backscatter, which in diastole correlates with the collagen
content of the myocardium.
Results. Integrated backscatter was higher in patients with
moderate or severely increased than in patients with normal
or slightly increased LV filling pressure (integrated back-
scatter: 51.0 ± 9.8 vs 41.6 ± 5.6%; P = 0.008). Integrated
backscatter was a strong and independent determinant of di-
astolic dysfunction (odds ratio = 1.212; P = 0.040).
Conclusion. Our data support the hypothesis that, in a se-
lected population of patients with ESRD undergoing hae-
modialysis, myocardial fibrosis is associated with LV
diastolic myocardial properties.
Keywords: diastolic function; ESRD; myocardial fibrosis; tissue
characterization
Introduction
Diastolic dysfunction, assessed by echocardiography, is as-
sociated with marked increase in all-cause mortality in
population-based studies and in patients with specific dis-
ease [1,2]. The central disturbance in diastolic dysfunction
involves abnormalities in myocardial relaxation and ven-
tricular compliance [3,4], which are related to structural
and functional cardiac abnormalities. Experimental and
clinical data demonstrated that such abnormalities are
mainly due to the increase of myocardial fibrosis [3]. As
a consequence of fibrosis, relaxation becomes slower and
left ventricular (LV) compliance decreases [3]. Thus, in
order to complete LV filling and achieve a sufficient
end-diastolic volume, which will provide adequate stroke
volume, the left ventricle needs filling pressure higher
than normal. Diastolic dysfunction, in fact, means that
the left ventricle fills at higher pressure. This condition is
frequent in patients with end-stage renal disease (ESRD)
due to increased LV thicknesses and fibrosis. Myocardial
fibrosis is particularly high in ESRD patients undergoing
haemodialysis, because of hypertension, increased volume
and hyperparathyroidism [5–8]. The relationship between
myocardial fibrosis and diastolic dysfunction has been
evaluated in many cardiac diseases [9–13], but no data exist
in patients with ESRD.
Echocardiography is a worldwide accepted non-invasive
method to assess diastolic function [1,14,15] and LV hyper-
trophy [16]. Moreover, there are consistent data in experi-
mental [17–19] and clinical settings [20,21], suggesting
that it can identify the presence of LV myocardial fibrosis
by using the integrated backscatter signal in diastole (IBS).
Thus, this study was aimed to understand the relation-
ship between LV diastolic function and LV fibrosis in
ESRD patients undergoing haemodialysis.
Materials and methods
Population
Thirty-eight patients with ESRD undergoing standard haemodialysis
(three times a week through an arteriovenous fistula) at the Department
of Nephrology of our University Hospital were considered for the study.
Patients with (i) a not high-quality 2D and Doppler echocardiogram from
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a parasternal long axis and four chamber views (n = 2); (ii) LV ejection
fraction <45% (n = 2); (iii) LV end-diastolic volume ≥102 ml/M2 (n = 3);
(iv) history of myocardial ischaemia, i.e. typical chest pain and/or positive
stress test, and/or infarction, i.e. hospitalization, elevation of cardiac en-
zymes, and/or regional myocardial thinning (i.e. <7 mm) or with regional
wall motion abnormalities (n = 2); (v) valvular heart disease (n = 1); (vi)
atrioventricular heart blocks or atrial fibrillation (n = 2); (vii) previous
pericardiectomy and/or suspected constrictive pericarditis (n = 1) were
excluded from the study. Thus, 25 patients constituted the final popula-
tion. They were 16 men and 9 women, with mean age of 47 ± 12, range
22–71 years. All patients were studied in the long interdialytic period,
within 24 hours preceding the haemodialysis; thus, patients were studied
on Monday and Tuesday. In each patient, their history of hypertension, i.e.
systolic blood pressure >140 mmHg or diastolic blood pressure >90
mmHg; history of dyslipidaemia (evidence of cholesterol >200 mg/dl
and/or triglyceride >150 mg/dl); and history of diabetes (fasting glucose
>126 mg/dl) were assessed. In each patient, haemoglobin and parathy-
roid hormone levels were evaluated. A haemoglobin level <13 g/dl and
<12g/dl identified anaemia in men and women, respectively; parathy-
roid hormone level was considered optimal when between 150 and
300 pg/dl. By bioelectric impedance analysis resistance, reactance and
extracellular water were measured in 10 patients. All enrolled patients
gave their informed consent prior to the study.
Echocardiography
Echocardiography was performed using a Hewlett–Packard imaging sys-
tem (Sonos 5500, Andover, Massachusetts) with an S3 transducer. Each
patient underwent standard M-mode, 2D and Doppler echocardiographic
study. In particular byM-Mode echocardiography, wemeasured LV internal
dimensions, interventricular septum and posterior wall thicknesses accord-
ing to the recommendations of the American Society of Echocardiography
[16]. LV mass was indexed to body surface area [16], increased LV mass
was defined in presence of a mass >95 g/M2 in women and >115 g/M2 in
men [15]. LV systolic function was estimated by four-chamber view using
the monoplane method of disks [16]. A non-dilated left ventricle was de-
fined in presence of LVend-diastolic volume <102 ml/M2 [22]; an LVejec-
tion fraction≥45%was considered normal [23]. The assessment of volume
overload was done by measuring the inferior vena cava diameter by subcos-
tal view and then normalized to body surface area (millimetre per square
metre) [24].
Patients underwent pulsed wave Doppler examination of mitral inflow
before and during loading manipulations, Valsava and legs-up manoeuvres
[1,25,26], which induce a decrease and an increase in cardiac preload, re-
spectively. Mitral flow velocities will decrease considerably during preload
reduction in presence of high filling pressure (so-called pseudonormal pat-
tern), whereas, in presence of normal filling pressure, they will show only
little changes. Furthermore, in patients with particularly elevated diastolic
dysfunction, LV filling pressure increases markedly and rapidly during
early filling so that filling is reduced during late diastole; in these cases,
mitral flow velocities will show an high early diastolic velocity with fast
deceleration time and a low diastolic velocity at end-diastole (so-called
restrictive pattern). This pattern can be observed at baseline studies, or
can develop during an increase in end-diastolic volume, such as during
legs-liftingmanoeuvre, which will be attained at the expense of a far greater
rise in filling pressure.
Moreover, by Doppler echocardiography, pulmonary venous inflow ve-
locities were recorded as well as by Doppler tissue imaging mitral annulus
velocities. Diastolic function was categorized according to the level of di-
astolic dysfunction: normal; mild, defined as impaired relaxation without
evidence of increased filling pressure; moderate, defined as impaired relax-
ation associated with moderate elevation of filling pressure or pseudonor-
mal filling; and severe, defined in presence of reversible, or inducible or
fixed restrictive filling [1,25,26]. Participants were required to have two
Doppler criteria consistent with moderate or severe diastolic dysfunction
to be so classified. Subjects with one criterion for moderate or severe dia-
stolic dysfunction, or those whose parameters were borderline and sugges-
tive of but not definitive for diastolic dysfunction were classified as
indeterminate rather than as normal and thus, excluded from the study [1].
According to these Doppler indexes, LV filling pressure in a given pa-
tient was judged to be normal or slightly increased in presence of normal
or prolonged relaxation pattern, and to be moderate or severely increased,
suggestive of filling pressure ≥18 mmHg [27], in presence of pseudonor-
mal or restrictive patterns [1,25–28].
Integrated backscatter is the relative measure of the total ultrasonic
energy backscattered by a small volume of the tissue under evaluation
[29]. It is produced when ultrasound interacts with components of the tis-
sue smaller than the transmitted wavelength; in this case, the reflected
signal is scattered in all directions, hence, part of it, the so-called back-
scatter, is directed towards the probe [29]. Integrated backscatter can be
evaluated during the overall cardiac cycle, the cyclic variation, or only
during the last part of diastole (end-diastole), IBS; this latter parameter
has been related to the entity of myocardial fibrosis [17–19]. Thus, to
measure IBS at septal and posterior wall segments, an elliptical region
of interest was placed in the mid-myocardial region and tracked manually
on frame by frame carefully avoiding the brighter endocardial borders,
and their position was adjusted in each frame so that the same area of
myocardium was analysed throughout end-diastole [12,30]. In each frame,
the Mean IBS was measured within the region of interest, expressed in
decibels and averaged across the end-diastole. Pericardial reflectivity
was measured in a single end-diastolic frame. IBS was then expressed
as percentage of pericardial reflectivity [12,29,30]. Finally, the mean of
septal and posterior wall IBS was also calculated [30] and thereafter,
called Mean IBS. As control group for IBS measurements, 10 normal sub-
ject sex and age matched were studied. They were four women and six
men with mean age of 41 ± 9, range 30–54 years.
Statistics
All statistical calculations were performed by using SPSS for Windows,
release 12 (SPSS, Chicago, Illinois). Data are given as mean ± 1 SD.
Student's t-test, one-way analysis of variance and Pearson correlation
were used when appropriate. Chi-squared was used for categorical vari-
ables. Odds ratios (OR) and 95% confidence limits (Cl) were calculated
by using univariate and multivariate logistic regression models. To evalu-
ate the variability of measurements, we calculated the percent precision
and the repeatability coefficient, as previously outlined [12]. A probability
value <0.05 was considered significant.
Results
Population
Two patients were excluded because of Doppler patterns
which were classified as indeterminate. Patients were on
haemodialysis for 48 ± 61 months, range 6 to 240 months.
In 12 patients, there was history of isolated hypertension,
combined to dyslipidaemia in four and to diabetes in two,
and to diabetes and dyslipidaemia in one patient; in the
one remaining patient, there was history of isolated dyslipi-
daemia. All but one patient had anaemia. Eleven patients
had hyperparathyroidism. Five patients had no classical car-
diovascular risk factors. All patients received medical ther-
apy with ACE-inhibitors and/ or AT1 blockers; in the
majority of patients, the drug dosage had changed continu-
ously from the beginning of haemodialysis to the date of our
control.
Diastolic function
In seven patients, there was evidence of normal diastolic
pattern, in seven of altered relaxation pattern, in three pa-
tients, there was evidence of pseudonormal pattern, and in
the remaining six, there was restrictive pattern. In these last
four patients, the restrictive pattern was elicited during
legs-up manoeuvre. Thus, in 14 patients, LV filling pres-
sure was judged to be normal or slightly abnormal, where-
as in nine patients, it was judged to be moderately to
severely increased. Clinical and echocardiographic find-
ings in these two groups of patients are reported in Table
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis 1951
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1 which shows no clinical and echocardiographic differ-
ences between the two groups (Table 1).
IBS
Intraobserver variability was tested in 10 consecutive pa-
tients: percent precision was 2%, and the repeatability co-
efficient was 1.35. Mean IBS was greater in patients with
ESRD than in controls (Mean IBS 45.2 ± 8.6 vs 36.8 ±
6.1%, P = 0.025) (Figure 1). Mean IBS resulted to be
higher in patients with moderate and severely in-
creased LV pressure than in patients with normal or slight-
ly abnormal LV pressure (Mean IBS 51.0 ± 9.8 vs 41.6 ±
5.6%; P = 0.008) (Figure 2). There were no differences of
Mean IBS value between patients without and with hyper-
tension (Mean IBS: 44.10 ± 7.3 vs 45.2 ± 7.0%; P = not
significant (NS)), diabetes (Mean IBS: 46.4 ± 7.9 vs 38.4
Fig. 1. Value of Mean IBS in the study population and in the control
group. ESRD = end-stage renal disease.
Table 1. Clinical and echocardiographic characteristics of patients divided based on their estimated LV filling pressure
Clinical and echocardiographic variables
Filling patterns
PNormal and altered relaxation [14] Pseudonormal and restrictive [9]
Age (years) 49.4 ± 11.2 42.7 ± 12.4 0.19
Dialysis duration (months) 40.7 ± 55.6 58.7 ± 69.6 0.52
History of hypertension 10 (71%) 7 (78%) 0.68
History of dyslipidaemia 2 (14%) 4 (44%) 0.87
History of diabetes 2 (14%) 1 (11%) 0.42
Left atrial diameter (mm) 41.6 ± 4.1 40.2 ± 5.5 0.51
LV mass (g/M2) 90.7 ± 25.2 85.5 ± 33.3 0.68
Increased LV mass (g/M2) 3 (21%) 2 (22%) 0.87
LV volume index (ml/M2) 53.9 ± 16.6 55.8 ± 18.5 0.80
LV ejection fraction (%) 59.6 ± 8.0 59.8 ± 9.6 0.96
Inferior vena cava index (mm/M2) 8.7 ± 2.2 8.6 ± 1.6 0.85
Resistance (Ohm) 536.2 + 42.7 535.5 + 123.4 0.99
Reactance (Ohm) 59.7 + 6.8 56.3 + 20.6 0.77
Extracellular water (%) 43.9 + 3.0 46.7 + 4.5 0.27
Haemoglobin (g/dl) 11.2 ± 1.2 10.4 ± 1.0 0.11
Parathyroid hormone (pg/ml) 353.4 ± 191.2 278.9 ± 188.9 0.39
LV = left ventricular.
Fig. 2. Value of Mean IBS in the population divided in two groups
according to the estimated left ventricular diastolic pressure.
Table 2. Determinants of diastolic dysfunction by univariate logistic
regression analysis
Variable Odds ratio Cl 95% P-value
Age 0.949 0.876–1.027 0.19
Dialysis duration (months) 1.005 0.990–1.020 0.50
History of hypertension 1.400 0.199–9.869 0.74
History of dyslipidaemia 1.083 0.154–7.642 0.12
History of diabetes 0.750 0.058–9.719 0.83
Left atrial diameter (mm) 0.936 0.775–1.131 0.49
LV mass (g/M2) 0.993 0.962–1.025 0.66
Increased LV mass (g/M2) 1.048 0.138–7.934 0.69
LV volume index (ml/M2) 0.977 0.862–1.108 0.79
LV ejection fraction (%) 1.033 0.906–1.010 0.95
Inferior vena cava index (mm/M2) 0.945 0.543–1.645 0.84
Resistance (Ohm) 1.000 0.983–1.017 0.99
Reactance (Ohm) 0.978 0.882–1.084 0.67
Extracellular water (%) 1.273 0.842–1.925 0.25
Haemoglobin (g/dl) 0.481 0.189–1.227 0.13
Parathyroid hormone (pg/ml) 0.998 0.992–1.003 0.63
Mean IBS 1.212 1.009–1.457 0.04
LV = left ventricular.
IBS = integrated backscatter.
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± 7.5%), dyslipidaemia (Mean IBS: 45.3 ± 9.9 vs 43.8 ±
6.3%; P = NS). Mean IBS was greater in patients with in-
creased LV mass than in patients with normal LV mass
(Mean IBS: 51.9 + 12.4 vs 43.0 + 7.1%; P = 0.046).
Determinants of increased LV pressure
By univariate logistic regression analysis, we analysed
the determinants of diastolic dysfunction. Diastolic dys-
function was defined in presence of a pseudonormal and
restrictive patterns. Thus, a binary logistic regression
analysis was performed. Only Mean IBS resulted to be
a determinant of diastolic dysfunction (Table 2).
Discussion
This study demonstrates that, in a selected population of pa-
tients with ESRD undergoing haemodialysis, LV diastolic
function worsens together with increasing of IBS, and that
IBS is a major determinant of diastolic dysfunction in
these patients.
LV diastolic dysfunction, as occurs in patients with hyper-
tension, diabetes mellitus and/or ageing, carries a substantial
risk of heart failure development and reduced survival, even
when it is asymptomatic or ‘preclinical’ [1,2]. Although di-
agnostic Doppler echocardiography has improved to identify
patients with such condition, therapeutic strategies are still
poor and will depend on research directed at the understand-
ing of the mechanisms of the disease [3,4].
In our study, 70% of patients showed Doppler indexes
of diastolic dysfunction, and within this group, in more
than 50%, such abnormalities were severe, i.e. indicating
a moderate to severe increase in LV diastolic pressure
(Table 1). This result was expected, because LV structural
alterations resulting in diastolic dysfunction, such as hy-
pertrophy and increased wall thickness associated with
increased myocardial fibrosis, are exaggerated in patients
with ESRD [6,30]. Such a high prevalence of diastolic
dysfunction may explain why patients with chronic kid-
ney disease have a high prevalence of diastolic heart fail-
ure [2] indicating that increased f illing pressure is
probably the most important haemodynamic alteration
in this group of patients. Moreover, diastolic dysfunction
is a frequent cause of hypotension during haemodialysis,
a condition which can contribute to LV remodelling [5].
The identification of the precise mechanism of increased
filling pressure may play a role in the management of
patients with ESRD.
IBS, myocardial fibrosis and cardiac structure in patients
with ESRD
The intensity of IBS signal depends on fibre orientation and
tissue structure, which is influenced by the ratio between
cardiomyocyte components and extracellular matrix. IBS
has been reported, in fact, to correlate with myocardial col-
lagen content, and therefore, represents an estimate of myo-
cardial fibrosis [17–21].
Experimental data suggest that LV hypertrophy in
uraemic rats is associated with an expansion of the myo-
cardial interstitium, with extracellular deposition of col-
lagen fiber [6]. Many structural lesions described in the
heart of uraemic animals have been confirmed in adult
patients with ESRD. Autopsy studies revealed that inter-
stitial myocardial fibrosis is more pronounced in dialysis
patients than in patients with primary hypertension, and
identified uraemia as an independent determinant of
these lesions [31]. Factors which determine such a high
increase in myocardial fibrosis have been demonstrated
in animal studies and are multiple and complex: hyper-
phosphataemia and increased level of parathyroid hor-
mone, which stimulate deposition of myocardial
fibrosis; activation of renin–angiotensin–aldosterone sys-
tem, which plays a role in increasing extracellular matrix
in patients with hypertension, and oxidative stress,
whose blockage decreases f ibrosis in uraemic rats
[32,33]. Thus, although a direct evidence of the entity
of myocardial fibrosis lacks in this study, it is reason-
able that IBS in our population of patients is related pri-
marily to interstitial fibrosis, as recently suggested by
other authors [30].
IBS and diastolic function in ESRD
Fibrosis raises the viscoelastic burden of the myocardi-
um and compromises relaxation, diastolic suction and
passive stiffness [3]. Pathophysiologic consequences in-
cluded elevated atrial pressure and ventricular filling
pressure. Such an elevated pressure may return to lower
values when preload reduces or can further augment
when preload increases. Thus, it is reasonable that pa-
tients with ESRD undergoing haemodialysis, in whom
there are multiple levels of preload between haemodia-
lysis sessions, have continuous variations in filling pres-
sure. These variations in pressure and load will allow
different patterns of diastolic filling by Doppler echocar-
diography [34]. By varying loading in the single patient
during echocardiography, we can better estimate the
presence and the degree of LV filling pressure increase
[25,26]. In fact, in our patients, variations of load dur-
ing echocardiography lead us to identify patients with
Doppler indexes suggestive of moderate to severely in-
creased LV diastolic pressure. The mechanism of such
dysfunction was related to increase Mean IBS, suggest-
ing an increased myocardial fibrosis (Figure 2). More-
over, in our population, although Mean IBS was
higher in patients with LV hypertrophy, this latter was
not a determinant of diastolic dysfunction, as shown
by the univariate analysis (Table 2). Thus, in patients
with ESRD undergoing haemodialysis with normal ejec-
tion fraction, without valve disease, myocardial fibrosis
has to be considered as a cause of diastolic dysfunction.
Conclusion
Our data suggest that myocardial fibrosis, a typical feature
of uraemic cardiomyopathy, is a determinant of LV diastol-
ic properties in a selected population of patients with
ESRD undergoing haemodialysis. Understanding the me-
chanisms linked to diastolic dysfunction may be important
for future treatment strategies in such patients.
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis 1953
 at FA
CO
LTA
' IN
G
EG
N
ERIA
 N
A
PO
LI - BIBLIO
TECA
 CEN
TRA
LE on July 23, 2012
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
Limitation of the study
The population sample of our study is small and highly
selected. In fact, patients with normal ejection fraction
without valve or ischaemic heart disease and without peri-
cardial disease are hard to find in the setting of patients
with ESRD undergoing haemodialysis. However, to inves-
tigate the relationship between IBS and diastolic function,
patients with confounding factors must to be excluded.
Thus, although the number of patients is small, we suggest
that our study adds information regarding the complex car-
diac pathophysiology of patients with ESRD undergoing
haemodialysis, and that it could be viewed as hypothesis
generating for further work in larger groups of patients.
Conflict of interest statement. Results presented in this paper have not
been published previously in whole or part, except in abstract format.
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